Global Drugs for Malaria Market Growth 2021-2026

Global Drugs for Malaria Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Malaria Consumption 2016-2026
2.1.2 Drugs for Malaria Consumption CAGR by Region
2.2 Drugs for Malaria Segment by Type
2.2.1 Aryl Aminoalcohol Compounds
2.2.2 Antifolate Compounds
2.2.3 Artemisinin Compounds
2.3 Drugs for Malaria Sales by Type
2.3.1 Global Drugs for Malaria Sales Market Share by Type (2016-2021)
2.3.2 Global Drugs for Malaria Revenue and Market Share by Type (2016-2021)
2.3.3 Global Drugs for Malaria Sale Price by Type (2016-2021)
2.4 Drugs for Malaria Segment by Application
2.4.1 Prevention
2.4.2 Treatment
2.4.3 Others
2.5 Drugs for Malaria Sales by Application
2.5.1 Global Drugs for Malaria Sale Market Share by Application (2016-2021)
2.5.2 Global Drugs for Malaria Revenue and Market Share by Application (2016-2021)
2.5.3 Global Drugs for Malaria Sale Price by Application (2016-2021)

3 Global Drugs for Malaria by Company
3.1 Global Drugs for Malaria Sales Market Share by Company
3.1.1 Global Drugs for Malaria Sales by Company (2019-2021)
3.1.2 Global Drugs for Malaria Sales Market Share by Company (2019-2021)
3.2 Global Drugs for Malaria Revenue Market Share by Company
3.2.1 Global Drugs for Malaria Revenue by Company (2019-2021)
3.2.2 Global Drugs for Malaria Revenue Market Share by Company (2019-2021)
3.3 Global Drugs for Malaria Sale Price by Company
3.4 Global Manufacturers Drugs for Malaria Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for Malaria Product Location Distribution
3.4.2 Players Drugs for Malaria Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Drugs for Malaria by Region
4.1 Global Drugs for Malaria by Region
4.1.1 Global Drugs for Malaria Sales by Region
4.1.2 Global Drugs for Malaria Revenue by Region
4.2 Americas Drugs for Malaria Sales Growth
4.3 APAC Drugs for Malaria Sales Growth
4.4 Europe Drugs for Malaria Sales Growth
4.5 Middle East & Africa Drugs for Malaria Sales Growth

5 Americas
5.1 Americas Drugs for Malaria Sales by Country
5.1.1 Americas Drugs for Malaria Sales by Country (2016-2021)
5.1.2 Americas Drugs for Malaria Revenue by Country (2016-2021)
5.2 Americas Drugs for Malaria Sales by Type
5.3 Americas Drugs for Malaria Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Drugs for Malaria Sales by Region
6.1.1 APAC Drugs for Malaria Sales by Region (2016-2021)
6.1.2 APAC Drugs for Malaria Revenue by Region (2016-2021)
6.2 APAC Drugs for Malaria Sales by Type
6.3 APAC Drugs for Malaria Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Drugs for Malaria by Country
7.1.1 Europe Drugs for Malaria Sales by Country (2016-2021)
7.1.2 Europe Drugs for Malaria Revenue by Country (2016-2021)
7.2 Europe Drugs for Malaria Sales by Type
7.3 Europe Drugs for Malaria Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Drugs for Malaria by Country
8.1.1 Middle East & Africa Drugs for Malaria Sales by Country (2016-2021)
8.1.2 Middle East & Africa Drugs for Malaria Revenue by Country (2016-2021)
8.2 Middle East & Africa Drugs for Malaria Sales by Type
8.3 Middle East & Africa Drugs for Malaria Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Drugs for Malaria Distributors
10.3 Drugs for Malaria Customer

11 Global Drugs for Malaria Market Forecast
11.1 Global Drugs for Malaria Forecast by Region
11.1.1 Global Drugs for Malaria Forecast by Regions (2021-2026)
11.2.2 Global Drugs for Malaria Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Drugs for Malaria Forecast by Type
11.7 Global Drugs for Malaria Forecast by Application

12 Key Players Analysis
12.1 Cipla
12.1.1 Cipla Company Information
12.1.2 Cipla Drugs for Malaria Product Offered
12.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Cipla Main Business Overview
12.1.5 Cipla Latest Developments
12.2 Guilin Pharmaceutical
12.2.1 Guilin Pharmaceutical Company Information
12.2.2 Guilin Pharmaceutical Drugs for Malaria Product Offered
12.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Guilin Pharmaceutical Main Business Overview
12.2.5 Guilin Pharmaceutical Latest Developments
12.3 IPCA Laboratories
12.3.1 IPCA Laboratories Company Information
12.3.2 IPCA Laboratories Drugs for Malaria Product Offered
12.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 IPCA Laboratories Main Business Overview
12.3.5 IPCA Laboratories Latest Developments
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Information
12.4.2 GlaxoSmithKline Drugs for Malaria Product Offered
12.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 GlaxoSmithKline Main Business Overview
12.4.5 GlaxoSmithKline Latest Developments
12.5 Mylan Labs
12.5.1 Mylan Labs Company Information
12.5.2 Mylan Labs Drugs for Malaria Product Offered
12.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Mylan Labs Main Business Overview
12.5.5 Mylan Labs Latest Developments
12.6 Roche
12.6.1 Roche Company Information
12.6.2 Roche Drugs for Malaria Product Offered
12.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Roche Main Business Overview
12.6.5 Roche Latest Developments
12.7 Novartis
12.7.1 Novartis Company Information
12.7.2 Novartis Drugs for Malaria Product Offered
12.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novartis Main Business Overview
12.7.5 Novartis Latest Developments
12.8 Sanofi Aventis
12.8.1 Sanofi Aventis Company Information
12.8.2 Sanofi Aventis Drugs for Malaria Product Offered
12.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sanofi Aventis Main Business Overview
12.8.5 Sanofi Aventis Latest Developments
12.9 Ajanta Pharma
12.9.1 Ajanta Pharma Company Information
12.9.2 Ajanta Pharma Drugs for Malaria Product Offered
12.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Ajanta Pharma Main Business Overview
12.9.5 Ajanta Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Drugs for Malaria Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Aryl Aminoalcohol Compounds
Table 3. Major Players of Antifolate Compounds
Table 4. Major Players of Artemisinin Compounds
Table 5. Global Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 6. Global Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 7. Global Drugs for Malaria Revenue by Type (2016-2021) & ($ million)
Table 8. Global Drugs for Malaria Revenue Market Share by Type (2016-2021)
Table 9. Global Drugs for Malaria Sale Price by Type (2016-2021)
Table 10. Global Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 11. Global Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 12. Global Drugs for Malaria Value by Application (2016-2021)
Table 13. Global Drugs for Malaria Revenue Market Share by Application (2016-2021)
Table 14. Global Drugs for Malaria Sale Price by Application (2016-2021)
Table 15. Global Drugs for Malaria Sales by Company (2019-2021) & (K Units)
Table 16. Global Drugs for Malaria Sales Market Share by Company (2019-2021)
Table 17. Global Drugs for Malaria Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Drugs for Malaria Revenue Market Share by Company (2019-2021)
Table 19. Global Drugs for Malaria Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Drugs for Malaria Producing Area Distribution and Sales Area
Table 21. Players Drugs for Malaria Products Offered
Table 22. Drugs for Malaria Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drugs for Malaria Sales by Region (2016-2021) (K Units)
Table 26. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
Table 27. Global Drugs for Malaria Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Drugs for Malaria Revenue Market Share by Region (2016-2021)
Table 29. Americas Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 30. Americas Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 31. Americas Drugs for Malaria Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 33. Americas Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 34. Americas Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 35. Americas Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 36. Americas Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 37. APAC Drugs for Malaria Sales by Region (2016-2021) & (K Units)
Table 38. APAC Drugs for Malaria Sales Market Share by Region (2016-2021)
Table 39. APAC Drugs for Malaria Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Drugs for Malaria Revenue Market Share by Region (2016-2021)
Table 41. APAC Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 42. APAC Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 43. APAC Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 44. APAC Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 45. Europe Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 46. Europe Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 47. Europe Drugs for Malaria Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 49. Europe Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 50. Europe Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 51. Europe Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 52. Europe Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Drugs for Malaria Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Drugs for Malaria
Table 62. Key Application and Potential Industries of Drugs for Malaria
Table 63. Key Challenges of Drugs for Malaria
Table 64. Key Trends of Drugs for Malaria
Table 65. Drugs for Malaria Distributors List
Table 66. Drugs for Malaria Customer List
Table 67. Global Drugs for Malaria Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Drugs for Malaria Consumption Market Forecast by Region
Table 69. Global Drugs for Malaria Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Drugs for Malaria Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Drugs for Malaria Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Drugs for Malaria Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Drugs for Malaria Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Drugs for Malaria Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Drugs for Malaria Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Drugs for Malaria Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Drugs for Malaria Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Drugs for Malaria Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Drugs for Malaria Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Drugs for Malaria Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Drugs for Malaria Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Drugs for Malaria Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Drugs for Malaria Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Drugs for Malaria Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Drugs for Malaria Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Drugs for Malaria Revenue Market Share Forecast by Application (2021-2026)
Table 87. Cipla Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Drugs for Malaria Product Offered
Table 89. Cipla Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. Cipla Main Business
Table 91. Cipla Latest Developments
Table 92. Guilin Pharmaceutical Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 93. Guilin Pharmaceutical Drugs for Malaria Product Offered
Table 94. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. Guilin Pharmaceutical Main Business
Table 96. Guilin Pharmaceutical Latest Developments
Table 97. IPCA Laboratories Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 98. IPCA Laboratories Drugs for Malaria Product Offered
Table 99. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. IPCA Laboratories Main Business
Table 101. IPCA Laboratories Latest Developments
Table 102. GlaxoSmithKline Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 103. GlaxoSmithKline Drugs for Malaria Product Offered
Table 104. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 105. GlaxoSmithKline Main Business
Table 106. GlaxoSmithKline Latest Developments
Table 107. Mylan Labs Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Labs Drugs for Malaria Product Offered
Table 109. Mylan Labs Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 110. Mylan Labs Main Business
Table 111. Mylan Labs Latest Developments
Table 112. Roche Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 113. Roche Drugs for Malaria Product Offered
Table 114. Roche Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 115. Roche Main Business
Table 116. Roche Latest Developments
Table 117. Novartis Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Drugs for Malaria Product Offered
Table 119. Novartis Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Sanofi Aventis Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Aventis Drugs for Malaria Product Offered
Table 124. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 125. Sanofi Aventis Main Business
Table 126. Sanofi Aventis Latest Developments
Table 127. Ajanta Pharma Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 128. Ajanta Pharma Drugs for Malaria Product Offered
Table 129. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 130. Ajanta Pharma Main Business
Table 131. Ajanta Pharma Latest Developments
List of Figures
Figure 1. Picture of Drugs for Malaria
Figure 2. Drugs for Malaria Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for Malaria Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Drugs for Malaria Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Drugs for Malaria Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Aryl Aminoalcohol Compounds
Figure 10. Product Picture of Antifolate Compounds
Figure 11. Product Picture of Artemisinin Compounds
Figure 12. Global Drugs for Malaria Sales Market Share by Type in 2020
Figure 13. Global Drugs for Malaria Revenue Market Share by Type (2016-2021)
Figure 14. Drugs for Malaria Consumed in Prevention
Figure 15. Global Drugs for Malaria Market: Prevention (2016-2021) & (K Units)
Figure 16. Drugs for Malaria Consumed in Treatment
Figure 17. Global Drugs for Malaria Market: Treatment (2016-2021) & (K Units)
Figure 18. Drugs for Malaria Consumed in Others
Figure 19. Global Drugs for Malaria Market: Others (2016-2021) & (K Units)
Figure 20. Global Drugs for Malaria Sales Market Share by Application (2016-2021)
Figure 21. Global Drugs for Malaria Revenue Market Share by Application in 2020
Figure 22. Drugs for Malaria Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Drugs for Malaria Revenue Market Share by Company in 2020
Figure 24. Global Drugs for Malaria Sales Market Share by Regions (2016-2021)
Figure 25. Global Drugs for Malaria Revenue Market Share by Region in 2020
Figure 26. Americas Drugs for Malaria Sales 2016-2021 (K Units)
Figure 27. Americas Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 28. APAC Drugs for Malaria Sales 2016-2021 (K Units)
Figure 29. APAC Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 30. Europe Drugs for Malaria Sales 2016-2021 (K Units)
Figure 31. Europe Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Drugs for Malaria Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 34. Americas Drugs for Malaria Sales Market Share by Country in 2020
Figure 35. Americas Drugs for Malaria Revenue Market Share by Country in 2020
Figure 36. Americas Drugs for Malaria Sales Market Share by Type in 2020
Figure 37. Americas Drugs for Malaria Sales Market Share by Application in 2020
Figure 38. United States Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Drugs for Malaria Sales Market Share by Region in 2020
Figure 43. APAC Drugs for Malaria Revenue Market Share by Regions in 2020
Figure 44. APAC Drugs for Malaria Sales Market Share by Type in 2020
Figure 45. APAC Drugs for Malaria Sales Market Share by Application in 2020
Figure 46. China Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Drugs for Malaria Sales Market Share by Country in 2020
Figure 53. Europe Drugs for Malaria Revenue Market Share by Country in 2020
Figure 54. Europe Drugs for Malaria Sales Market Share by Type in 2020
Figure 55. Europe Drugs for Malaria Sales Market Share by Application in 2020
Figure 56. Germany Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Drugs for Malaria Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Drugs for Malaria Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Drugs for Malaria Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Drugs for Malaria Sales Market Share by Application in 2020
Figure 65. Egypt Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Dihydroartemisinin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......

Global Artemisinin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......

Dihydroartemisinin - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99

The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......

Global Artemisinin Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Artemisinin Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......

Global Artemisinin Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs